/PRNewswire/ The "Global Alzheimer s Therapeutics Market (2022-2027) by Diagnostics, Drug Class, Distribution, and Geography, Competitive Analysis and the.
Bayer presented the latest progress in the ongoing transformation of its pharmaceutical business focusing on accelerating innovative healthcare solutions for the benefits of patients and delivering long-term, sustainable business growth at its annual Pharma Media Day 2023 organised recently in Berlin.
AskBio to Present Phase 1b Results Investigating AB-1005 (formerly AAV2-GDNF) as Treatment for Parkinson’s Disease at AD/PDTM 2023 International Conference on Alzheimer's and Parkinson's Diseases
/PRNewswire/ Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, will.
Pharma - At its annual Pharma Media Day 2023, Bayer presented the latest progress in the ongoing transformation of its pharmaceutical business focusing on